Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien)

Aetna covers Retisert and Yutiq for chronic noninfectious posterior uveitis refractory or intolerant to conventional corticosteroid/immunosuppressive therapy, and Iluvien for diabetic macular edema only in patients previously treated with corticosteroids who did not have a clinically significant rise in intraocular pressure (relevant CPT/HCPCS codes covered if selection criteria are met). Retisert/Yutiq and Iluvien are contraindicated and not medically necessary with active ocular or periocular infections (Iluvien is also not covered for glaucoma with cup-to-disc ratio >0.8), and certain codes (e.g., CPT 65770, HCPCS C1814) are not covered for these indications.

"Retisert (fluocinolone acetonide intravitreal 0."

Sign up to see full coverage criteria, indications, and limitations.